Title |
YM155-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting / Martin Michaelis, Mark N. Wass, Ian Reddin, Yvonne Voges, Florian Rothweiler, Stephanie Hehlgans, Jaroslav Cinatl, Marco Mernberger, Andrea Nist, Thorsten Stiewe, Franz Rödel, Jindrich Cinatl |
|---|---|
Involved |
Martin Michaelis (Verfasser)
Mark N. Wass (Verfasser) Ian Reddin (Verfasser) Yvonne Voges (Verfasser)
Florian Rothweiler (Verfasser)
Stephanie Hehlgans (Verfasser) Jaroslav Cinatl (Verfasser) Marco Mernberger (Verfasser) Andrea Nist (Verfasser) Thorsten Stiewe (Verfasser) Franz Rödel (Verfasser) Jindrich Cinatl (Verfasser) |
Published |
Frankfurt am Main: Universitätsbibliothek Johann Christian Senckenberg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
acquired drug resistance
biomarkers therapy monitoring neuroblastoma
BIRC5
survivin intrinsic drug resistance |
DDC notation |
|
Persistent identifier |
|
Further information |
In: Cancers 12.2020, 1080, doi:10.3390/cancers12051080 |
Record ID |
1209982137 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: